Ann Oncol

1. GERMANI MM, Modest DP
   Response to 'A temporal paradox in the proposed risk-adjusted surveillance algorithm for metastatic colorectal cancer'.
   Ann Oncol. 2025 Oct 21:S0923-7534(25)04784-2. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   
2. CANN C, Eng C
   Positioning EGFR re-treatment in modern metastatic colorectal cancer: insights from PARERE.
   Ann Oncol. 2025 Oct 18:S0923-7534(25)04952-X. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   
3. CIRACI P, Germani MM, Pietrantonio F, Manca P, et al
   Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.
   Ann Oncol. 2025 Oct 18:S0923-7534(25)04934-8. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   

   
   Ann Surg Oncol

4. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
   ASO Visual Abstract: Rurality and Use of Metastasis-Directed Therapies in Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
   Ann Surg Oncol. 2025 Oct 18. doi: 10.1245/s10434-025-18586.
   

   >> Share

   
   

   
   BMC Cancer

5. SHEN Y, Bao T, Yuan T, Zhang Y, et al
   Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.
   BMC Cancer. 2025;25:1628.
   

   >> Share

   
   

   
   Cancer Lett

6. MA C, Awosika JA, Monge C, Coffman-D'Annibale K, et al
   Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorec
   Cancer Lett. 2025;632:217975.
   

   >> Share

   
   

   
   Dis Colon Rectum

7. EFETOV SK, Rychkova AK, Krasnov YP
   Retroperitoneal Approach for Total Colectomy in Minimally Invasive Treatment of Synchronous Multiple Colon Cancer.
   Dis Colon Rectum. 2025 Oct 20. doi: 10.1097/DCR.0000000000003982.
   

   >> Share

   
   

   
   Gastroenterology

8. NGAMRUENGPHONG S, Othman MO, Wang AY, Yang D, et al
   AGA Clinical Practice Update on Endoscopic Resection for Early Colorectal Cancer: Commentary.
   Gastroenterology. 2025 Oct 20:S0016-5085(25)05979.
   

   >> Share

   
   
9. MONAHAN K, Hampel H, Stoffel E, Kupfer SS, et al
   In Our Scope of Practice: Genetic Risk Assessment and Testing for Gastrointestinal Cancers and Polyposis in Gastroenterology.
   Gastroenterology. 2025;169:1147-1165.
   

   >> Share

   
   

   
   Gastrointest Endosc

10. ANG TL
    Cost-effectiveness of lowering the age of colorectal cancer screening in average-risk individuals to 45 years in Asia.
    Gastrointest Endosc. 2025;102:726-727.
    

    >> Share

    
    

    
    Int J Cancer

11. HAAS CB, Ocampo R, Liu D, Zuniga M, et al
    Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082.
    

    >> Share

    
    
12. YU Z, Derksen M, Te Pas BM, Ladstatter S, et al
    Single-cell multi-omics characterize colorectal tumors, adjacent healthy tissue and matched (tumor) organoids identifying CRC-unique features.
    Int J Cancer. 2025;157:2619-2634.
    

    >> Share

    
    

    
    Int J Colorectal Dis

13. LAUWEREINS L, D'Hoore A, Coeckelberghs E, Fieuws S, et al
    A 2-year prospective study on the evolution of Low Anterior Resection Syndrome (LARS) following rectal cancer surgery.
    Int J Colorectal Dis. 2025;40:220.
    

    >> Share

    
    
14. KUTLU B, Benlice C, Seker ME, Kocaay AF, et al
    The emperor has no clothes-the need for standardized anatomical segment definitions in the management of colon cancer.
    Int J Colorectal Dis. 2025;40:219.
    

    >> Share

    
    
15. TAN S, Zeng P, Liu S, Yang Y, et al
    Effectiveness of artificial intelligence-assisted colonoscopy in detecting and diagnosing colorectal tumors: a systematic review and network meta-analysis.
    Int J Colorectal Dis. 2025;40:218.
    

    >> Share

    
    
16. LI Y, Wang X, Wang X, Jia X, et al
    Preliminary investigation of the association between desmoglein-2 expression and patient prognosis following radical surgery for colon cancer.
    Int J Colorectal Dis. 2025;40:217.
    

    >> Share

    
    

    
    Lancet

17. HECHT JR, Park YS, Tabernero J, Lee MA, et al
    Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
    Lancet. 2025 Oct 20:S0140-6736(25)02025-2. doi: 10.1016/S0140-6736(25)02025.
    

    >> Share

    
    

    
    Oncogene

18. HU Y, Liu W, Qiang D, Huang K, et al
    Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer.
    Oncogene. 2025 Oct 19. doi: 10.1038/s41388-025-03599.
    

    >> Share

    
    

    
    PLoS One

19. BUJANG NNA, Kong YC, Thiagarajan M, Roslani AC, et al
    Development and validation of a dual language needs assessment tool for people living with colorectal cancer (NeAT-CC).
    PLoS One. 2025;20:e0332930.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share